These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3756916)

  • 1. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.
    Creasey AA; Reynolds MT; Laird W
    Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL; Stampfl S; Zimmerman RJ
    Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor.
    Manetta A; Emma D; Gamboa G; Liao S; Berman M; DiSaia P
    Gynecol Oncol; 1993 Jul; 50(1):38-44. PubMed ID: 8349163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
    Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
    J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
    Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
    Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.
    Balkwill FR; Lee A; Aldam G; Moodie E; Thomas JA; Tavernier J; Fiers W
    Cancer Res; 1986 Aug; 46(8):3990-3. PubMed ID: 2425938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
    Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
    Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
    Balkwill FR; Ward BG; Moodie E; Fiers W
    Cancer Res; 1987 Sep; 47(18):4755-8. PubMed ID: 3113722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
    Wright P; Zheng C; Moyana T; Xiang J
    Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
    Watanabe N; Niitsu Y; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
    Cancer Res; 1988 Feb; 48(3):650-3. PubMed ID: 3335027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of tumor necrosis factor (TNF) in tumor-bearing mice].
    Tamura K; Ishida N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1369-78. PubMed ID: 6378101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice.
    Takahashi N; Brouckaert P; Fiers W
    Cancer Res; 1991 May; 51(9):2366-72. PubMed ID: 1826631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of IL-12 on human ovarian tumors engrafted into SCID mice.
    Silver DF; Hempling RE; Piver MS; Repasky EA
    Gynecol Oncol; 1999 Feb; 72(2):154-60. PubMed ID: 10021294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.